{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2022"],"condition":["","BRAF V600E-mutant metastatic colorectal cancer"],"disease":["","Braf V600e-mutant Metastatic Colorectal Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/33441"],"study_start_month":["7"],"repository":["ECRIN MDR"],"study_status":["Active, not recruiting"],"additional_accession":[]},"is_claimable":false,"name":"A Retrospective Observational Study in the Expanded Access Program of Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer (BEACON EAP Follow-up Study )","description":"Primary outcome(s): Overall survival","dates":{"creation":"2022-07-15"},"accession":"33441","cross_references":{"Japan Primary Registries Network":["JPRN-jRCT1031220225"]}}